AstraZeneca
leaders in breast cancer treatment | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
8 of 42
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
dare | Dare Bioscience
ATAI
Investor Day
January 2022
why are there no approved treatments for | ATAI
BenevolentAI
Investor Conference
January 2023
using our platform for societal bene a covid treatment now approved for use by the non commercial collaboration rapid novel effective focused on dengue fever a major burden aims to deliver biological targets and drug candidates experimental validation in progress assays benefit lilt | BenevolentAI
Calliditas Therapeutics
IPO
June 2020
potential to be first approved treatment for | Calliditas Therapeutics
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights